Purple Biotech Receives Extension From Listing Qualifications Department Of Nasdaq To Regain Compliance With Minimum $1.00 Bid Price Requirement
Purple Biotech Receives Extension From Listing Qualifications Department Of Nasdaq To Regain Compliance With Minimum $1.00 Bid Price Requirement
purple biotech獲得納斯達克上市資格部門的延期，以符合最低1.00美元買盤要求
Purple Biotech Receives Extension From Listing Qualifications Department Of Nasdaq To Regain Compliance With Minimum $1.00 Bid Price Requirement
purple biotech獲得納斯達克上市資格部門的延期，以符合最低1.00美元買盤要求
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。